首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Expression of BRCA1, HER-1 (EGFR) and HER-2 in sporadic breast cancer and relationships to other clinicopathological prognostic features.
【24h】

Expression of BRCA1, HER-1 (EGFR) and HER-2 in sporadic breast cancer and relationships to other clinicopathological prognostic features.

机译:BRCA1,HER-1(EGFR)和HER-2在散发性乳腺癌中的表达及其与其他临床病理预后特征的关系。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The BRCA1 caretaker gene is associated with poor prognostic features in hereditary breast cancer and may also play a role in sporadic breast cancer (SBC). HER-1 and HER-2 overexpression is associated with adverse prognosis in SBC. We studied whether BRCA1 expression was associated with HER1, HER2 and other prognostic features in SBC. PATIENTS AND METHODS: Fifty newly-diagnosed SBC patients were studied for prognostic features and immunohistochemical expressions of BRCA1, HER-1 and HER-2. RESULTS: Tumors were positive for BRCA1 in 26%, HER-1 in 32% and HER-2 in 20% of cases. Lack of BRCA1 expression was associated with node metastases and decreased estrogen receptor. HER-2 expression was associated with young age, HER-1, Ki67 and decreased hormone receptors. No correlation was observed between BRCA1 and HER-1 or HER-2. CONCLUSION: In SBC, the lack of BRCA1 expression was associated with poor prognostic features, but unrelated to HER-1 and HER-2. HER2 and HER-1 were, however, highly correlated.
机译:背景:BRCA1看护基因与遗传性乳腺癌的不良预后特征相关,也可能在散发性乳腺癌(SBC)中起作用。 HER-1和HER-2过表达与SBC不良预后相关。我们研究了BRCA1表达是否与SBC中的HER1,HER2和其他预后特征相关。病人和方法:对50名新诊断的SBC患者进行了BRCA1,HER-1和HER-2的预后特征和免疫组化表达的研究。结果:BRCA1阳性的肿瘤占26%,HER-1阳性的占32%,HER-2阳性的占20%。 BRCA1表达的缺乏与淋巴结转移和雌激素受体减少有关。 HER-2表达与年轻,HER-1,Ki67和激素受体减少有关。在BRCA1与HER-1或HER-2之间未发现相关性。结论:在SBC中,缺乏BRCA1表达与不良预后有关,但与HER-1和HER-2无关。但是,HER2和HER-1高度相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号